Change in Orion Group Executive Management Board as of February 1st, 2024 – Julia Macharey appointed Senior Vice President, People & Culture
Julia Macharey
ORION CORPORATION
STOCK EXCHANGE RELEASE – CHANGES BOARD/MANAGEMENT/AUDITORS
22 August 2023 at 14.00 EEST
Change in Orion Group Executive Management Board as of February 1st, 2024 – Julia Macharey appointed Senior Vice President, People & Culture
Ms. Julia Macharey has been appointed Senior Vice President of Orion Group’s new People & Culture group-level function and member of the Executive Management Board of Orion Group as of February 1st 2024. She will report to President & CEO Liisa Hurme. She currently holds the position of Senior Vice President, Human Resources and Operational Development at Valmet and is a member of the Valmet Executive Team. Julia Macharey holds a Master of Science degree in Economics and a Bachelor of Arts degree.
“With this appointment, I wanted to support the implementation of our global growth strategy and to strengthen the building of Orion’s corporate culture. Based on her previous experience and track record, Julia Macharey will bring both global organizational and business perspective to Orion,” says Orion’s President & CEO Liisa Hurme.
“I am very excited about the opportunity of joining a team of world-class experts who endeavor to improve well-being through life-saving and life-improving medicines and treatments. Orion’s people-oriented culture based on working together to create high-quality products is only one of the many reasons why I am looking forward to supporting Orion on its growth path,” says Julia Macharey about the appointment.
The new People & Culture function will focus on developing Orion’s professionals, capabilities and company culture and supporting growth, and Human Resources will be at the heart of this new group-level function as of February 1st.
“Orion’s organisation has seen significant geographical expansion in recent years, and we want to continue developing our people and culture in a global and systematic way. I am excited about the new opportunities in this and I warmly welcome Julia to Orion and to our management team,” says Liisa Hurme.
ANNEX: CV of Julia Macharey
Julia Macharey
Born 1977
Finnish citizen
Education:
Master of Science in Economics, University of Jyväskylä, 2000
Bachelor of Arts (Intercultural Communication), University of Jyväskylä, 1999
Career:
Valmet
2019– Senior Vice President, Human Resources and Operational Development
2014–2019 Senior Vice President, Human Resources
Metso Corporation, Metso Paper
2012–2013 Senior Vice President, Human Resources of Metso Pulp, Paper and Power segment
Pöyry Plc
2007–2012 Vice President, Human Resources of Industry Business Group
Nokia Corporation
2006–2007 Senior Manager, Business HR of Manufacturing Solutions
2004–2006 Senior Manager, Business HR of Sourcing and Procurement
SCA Hygiene Products Ltd and GmbH
2000–2004 Human Resources Manager and various HR management responsibilities
Attachment:
- Julia Macharey (image)
Orion Corporation
Liisa Hurme
President and CEO |
Olli Huotari
SVP, Corporate Functions |
Contact person:
Liisa Hurme, President and CEO
tel. +358 50 966 2874, liisa.hurme@orion.fi
Contact person for the media:
Terhi Ormio, VP, Communications
tel. + 358 50 966 4646, terhi.ormio@orion.fi
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion’s net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.
Attachment